MedTrace Logo

A Multicentre, Retrospective Study to Evaluate the Outcome of HSCT Mismatch Unrelated Donors

NCT04598789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2021-11-26

No results posted yet for this study

Summary

The primary endpoint of the study was the acute GvHD incidence, the secondary endpoints were chronic GvHD incidence, overall survival (OS), transplant related mortality (TRM) incidence, relapse incidence (RI) and neutrophil and platelets engraftment after GvHD prophylaxis with ATG-CSA-MTX or PTCy-MMF-FK506

Conditions

  • Leukemia, Myeloid

Interventions

OTHER

no intervention

no intervention, observational study

Sponsors & Collaborators

  • Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-07
Primary Completion
2021-06-30
Completion
2021-09-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598789 on ClinicalTrials.gov